Filing Details

Accession Number:
0001209191-17-007809
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-03 18:21:40
Reporting Period:
2017-02-02
Filing Date:
2017-02-03
Accepted Time:
2017-02-03 18:21:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412067 Cascadian Therapeutics Inc. CASC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1188919 W Ted Love C/O Cascadian Therapeutics, Inc.
2601 Fourth Ave., Suite 500
Seattle WA 98121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-02-02 23,000 $4.24 27,209 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average sales price per share. The shares sold at prices ranging from $4.21 to $4.31 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer.
  2. Effective as of November 29, 2016, the issuer effected a 6-for-1 reverse split of its common stock. The number of shares above reflects the reverse stock split.